Heidi A. Peck

792 Elizabeth St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2025.

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2025.

Journal: Communicable diseases intelligence (2018)

Published: August 25, 2026

Antiviral Resistance Associated With Multiple Mutations Occurring in Seasonal Influenza A(H3N2) Virus in a Patient Treated With Oseltamivir.

Antiviral Resistance Associated With Multiple Mutations Occurring in Seasonal Influenza A(H3N2) Virus in a Patient Treated With Oseltamivir.

Journal: Clinical case reports

Published: March 20, 2026

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2024.

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2024.

Journal: Communicable diseases intelligence (2018)

Published: February 23, 2026

High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.

High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.

Journal: eLife

Published: February 23, 2026

Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity.

Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity.

Journal: Nature communications

Published: January 19, 2026

Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses.

Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: December 12, 2025

Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025.

Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025.

Journal: bioRxiv : the preprint server for biology

Published: September 15, 2025

Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025.

Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025.

Journal: Virus evolution

Published: September 11, 2025

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2023.

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2023.

Journal: Communicable diseases intelligence (2018)

Published: May 18, 2025

Influenza Vaccine Effectiveness in Australia During 2017-2019.

Influenza Vaccine Effectiveness in Australia During 2017-2019.

Journal: Influenza and other respiratory viruses

Published: April 08, 2025

High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.

High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.

Journal: bioRxiv : the preprint server for biology

Published: March 31, 2025

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial.

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial.

Journal: The Journal of infectious diseases

Published: January 16, 2025

Showing 1-12 of 34

Last Updated: 09/26/2026